Johannes Schulte

29PUBLICATIONS
290CO-AUTHORS
Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

|Feb 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

Marius Ludwig, Kerstin Ahrens, Annika Winkler

|Mar 31, 2025
Iron overload in HFE-related hemochromatosis severely impairs Vδ2+ γδ T-cell homeostasis.

Derya Erdogdu, Ina Becoku, Valerie Huber

|Jan 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Leo Mascarenhas, Steven G DuBois, Catherine M Albert

|Jan 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

Tim Flaadt, Jonas Rehm, Thorsten Simon

Pageof 5

Frequent Collaborators

13 joint publications

Angelika Eggert

10 joint publications

Hedwig E Deubzer

9 joint publications

Anton G Henssen

7 joint publications

Annette Künkele